Verapamil and betamimetics
Taleb, A.L.; Bouchetara, K.
Revue Francaise de Gynecologie et d'Obstetrique 79(6): 465-467
1984
ISSN/ISBN: 0035-290X PMID: 6152076 Document Number: 224396
The authors review the studies which have been conducted on combination therapy with verapamil and beta-mimetics. This form of treatment does not appear to be wise or effective in clinical practice and should be rejected because the risks far outweigh the purely subjective benefits.
Document emailed within 1 workday
Related Documents
Griot, J.P. 1985: Maternal risks of betamimetics Revue Francaise de Gynecologie et d'Obstetrique 80(12): 911-914During, R.; Krzyzanowski, A. 1985: Use of betamimetics in performing cervical cerclage Zentralblatt für Gynakologie 107(8): 496-499
Carrasco, R.M.; Ribeiro, L.C.; Luna, R.L. 1979: Verapamil in the treatment of severe rapid onset hypertension. Potentiation of hypotensive drugs and sensitization of pressoreceptors by serial infusion of verapamil Arquivos Brasileiros de Cardiologia 32(2): 129-133
De Lio, U.; Maiolino, P.; Trevisan, G.; Cappelletti, F.; Vincenzi, M. 1981: Incidence of arrhythmias in acute myocardial infarct treated with verapamil, digitalis and a verapamil-digitalis combination Bollettino Della Societa Italiana di Cardiologia 26(9): 857-865
Gal, J.; Desai, D.M.; Bloedow, D.C.; Miller, L.V.; Murphy, R.C. 1986: On the conversion of verapamil to carboxy verapamil Research Communications in Chemical Pathology and Pharmacology 52(3): 387-390
Yoshida, K.; Takahashi, T.; Nakame, Y.; Saitoh, H.; Horiuchi, S.; Kaneoya, F.; Negishi, T. 1987: Bladder instillation of verapamil as a means of enhancing the efficacy of chemotherapy in superficial bladder carcinoma: influence of bladder instillation of verapamil on the cardiovascular system Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(2): 506-510
McGoon, M.D.; Vlietstra, R.E.; Holmes, D.R.; Osborn, J.E. 1982: The clinical use of verapamil Mayo Clinic Proceedings 57(8): 495-510
Cutie, M.R. 1983: Verapamil precipitation Annals of Internal Medicine 98(5 Pt 1): 672
Burgunder, J.M.; Abernethy, D.R.; Lauterburg, B.H. 1988: Liver injury due to verapamil Hepato-Gastroenterology 35(4): 169-170
Schomerus, M.; Eichelbaum, M.; Stieren, B.; Spiegelhalter, B.; Dengler, H.J. 1976: Pharmacokinetic behavior of verapamil in man Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1697-1699
Duchêne-Marullaz, P. 1984: Verapamil: antiangina effects Therapie 39(2): 153-165
Oates, H.F. 1979: Verapamil as an antihypertensive agent New Zealand Medical Journal 89(630): 142-143
Pina, M.A.; Ara, J.R.; Remírez, A.; Castiella, J. 1998: Verapamil and acute dystonia Journal of Clinical Pharmacy and Therapeutics 23(1): 79-80
Gushi, N.; Mateos, D.A.; Magaldi, J.B. 1976: Clinical use of verapamil in hypertensive crisis Arquivos Brasileiros de Cardiologia 29(1): 67-74
Hailer, N.P.; Blaheta, R.A.; Harder, S.; Scholz, M.; Encke, A.; Markus, B.H. 1994: In vitro studies on immunosuppression with verapamil Zentralblatt für Chirurgie 119(5): 347-354
Rodríguez, V.; Barriales, V.; Moris, C.; Barriales, R. 1997: Slow-release verapamil poisoning Anales de Medicina Interna 14(3): 159
Höschl, C.; Vacková, J.; Janda, B. 1992: Mood stabilizing effect of verapamil Bratislavske Lekarske Listy 93(4): 208-209
Zou, H.L.; Wei, E.Q.; Yang, W.; Bian, R.L. 1985: Effect of verapamil on the action of isoproterenol Yao Xue Xue Bao 20(3): 173-177
Sarkari, N.B.; Singh, M.M.; Barthwal, S.P.; Bagga, C.B.; Gupta, A.K. 1979: Verapamil in supraventricular paroxysmal tachycardia Indian Heart Journal 31(5): 263-268
Drici, M.D.; Jacomet, Y.; Iacono, P.; Lapalus, P. 1993: Is verapamil also a non-selective beta blocker? International Journal of Clinical Pharmacology Therapy and Toxicology 31(1): 27-30